National Comprehensive Cancer Network

Educational Events & Programs

NCCN 4^th Annual Congress:
Hematologic Malignancies™
Program Overview

The treatment of hematologic malignancies is increasingly complex. Issues relating to pathology, transplantation, and various new therapies require oncologists and hematologists to stay abreast of new advances. In addition, targeted therapies and oral treatments bring new benefits to patients. This Congress will focus on the new approaches that have been incorporated into patient management, including the use of drugs, biologics, and diagnostics. The agenda will address acute myeloid leukemia, chronic myeloid leukemia, chronic lymphocytic leukemia, multiple myeloma, non-Hodgkin’s lymphomas, and supportive care issues in hematologic malignancies.

This overview is subject to change as agenda is finalized.